表 1.
胃癌组织中CPNE3的表达量与胃癌患者临床及病理参数间的关系
Relationship between CPNE3 expression level and clinicopathological parameters of gastric cancer patients [n (%)]
| Characteristic | n | CPNE3 expression | χ 2 | Ρ | |
| Low (n=52) | High (n=52) | ||||
| Gender | 0.175 | 0.676 | |||
| Male | 70 | 36 (51.4) | 34 (48.6) | ||
| Female | 34 | 16 (47.1) | 18 (52.9) | ||
| Age (year) | 3.261 | 0.071 | |||
| ＜60 | 41 | 25 (61.0) | 16 (39.0) | ||
| ≥60 | 63 | 27 (42.9) | 36 (57.1) | ||
| CEA | 17.120 | ＜0.001 | |||
| ＜5 μg/L | 47 | 34 (72.3) | 13 (27.7) | ||
| ≥5 μg/L | 57 | 18 (31.6) | 39 (68.4) | ||
| CA19-9 | 15.592 | ＜0.001 | |||
| ＜37 kU/L | 46 | 33 (71.7) | 13 (28.3) | ||
| ≥37 kU/L | 58 | 19 (32.8) | 39 (67.2) | ||
| Tumor size | 0.650 | 0.420 | |||
| ＜5 cm | 40 | 22 (55.0) | 18 (45.0) | ||
| ≥5 cm | 64 | 30 (46.9) | 34 (53.1) | ||
| Histological type | 0.187 | 0.665 | |||
| Adenocarcinoma | 74 | 38 (51.4) | 36 (48.6) | ||
| Other | 30 | 14 (46.7) | 16 (53.3) | ||
| Pathological grading | 0.041 | 0.839 | |||
| G1-G2 | 39 | 19 (48.7) | 20 (51.3) | ||
| G3-G4 | 65 | 33 (50.8) | 32 (49.2) | ||
| T stage | 26.351 | ＜0.001 | |||
| T1-T2 | 46 | 36 (78.3) | 10 (21.7) | ||
| T3-T4 | 58 | 16 (27.6) | 42 (72.4) | ||
| N stage | 12.480 | ＜0.001 | |||
| N0-N1 | 54 | 36 (66.7) | 18 (33.3) | ||
| N2-N3 | 50 | 16 (32.0) | 34 (68.0) | ||